Nathan Theodore Connell, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
von Willebrand Diseases | 16 | 2023 | 127 | 5.650 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 4 | 2023 | 232 | 1.220 |
Why?
|
Hematology | 5 | 2021 | 219 | 1.110 |
Why?
|
Thrombosis | 5 | 2021 | 2966 | 1.110 |
Why?
|
Hemophilia A | 4 | 2023 | 351 | 1.090 |
Why?
|
Venous Thromboembolism | 6 | 2022 | 1668 | 1.020 |
Why?
|
Hematologic Diseases | 2 | 2020 | 498 | 0.990 |
Why?
|
Heparin | 4 | 2021 | 1636 | 0.970 |
Why?
|
Factor XIII | 1 | 2024 | 59 | 0.960 |
Why?
|
von Willebrand Factor | 11 | 2023 | 668 | 0.910 |
Why?
|
Angiodysplasia | 1 | 2023 | 23 | 0.900 |
Why?
|
Blood Coagulation Disorders, Inherited | 1 | 2021 | 18 | 0.810 |
Why?
|
Anticoagulants | 7 | 2021 | 4595 | 0.800 |
Why?
|
Hemoglobinuria, Paroxysmal | 2 | 2019 | 102 | 0.770 |
Why?
|
Dalteparin | 1 | 2019 | 42 | 0.710 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2020 | 188 | 0.680 |
Why?
|
Plasmacytoma | 1 | 2019 | 182 | 0.640 |
Why?
|
Pyridines | 2 | 2019 | 2818 | 0.600 |
Why?
|
Oxazines | 1 | 2019 | 298 | 0.600 |
Why?
|
Hemorrhage | 8 | 2022 | 3461 | 0.580 |
Why?
|
Complement System Proteins | 1 | 2020 | 795 | 0.570 |
Why?
|
Skull Base Neoplasms | 1 | 2019 | 284 | 0.520 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2016 | 339 | 0.500 |
Why?
|
Plasma Exchange | 1 | 2015 | 155 | 0.500 |
Why?
|
Vitamin K | 1 | 2016 | 294 | 0.490 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 2015 | 131 | 0.480 |
Why?
|
Perioperative Care | 1 | 2021 | 997 | 0.480 |
Why?
|
ADAM Proteins | 1 | 2015 | 242 | 0.470 |
Why?
|
Thiazoles | 2 | 2023 | 1484 | 0.450 |
Why?
|
Thrombocytopenia | 3 | 2021 | 1171 | 0.430 |
Why?
|
Prednisone | 2 | 2018 | 1567 | 0.410 |
Why?
|
Menorrhagia | 2 | 2022 | 63 | 0.410 |
Why?
|
Hemostasis | 4 | 2022 | 458 | 0.400 |
Why?
|
Cost-Benefit Analysis | 3 | 2019 | 5385 | 0.400 |
Why?
|
Splenosis | 1 | 2011 | 4 | 0.400 |
Why?
|
Anemia, Refractory, with Excess of Blasts | 1 | 2010 | 17 | 0.390 |
Why?
|
Gastric Outlet Obstruction | 1 | 2011 | 56 | 0.390 |
Why?
|
Cryptogenic Organizing Pneumonia | 1 | 2010 | 29 | 0.390 |
Why?
|
Splenic Diseases | 1 | 2011 | 94 | 0.380 |
Why?
|
Polysaccharides | 1 | 2016 | 1051 | 0.360 |
Why?
|
Blood Transfusion | 1 | 2016 | 1296 | 0.360 |
Why?
|
Tranexamic Acid | 2 | 2022 | 146 | 0.360 |
Why?
|
Dexamethasone | 2 | 2016 | 1949 | 0.350 |
Why?
|
Methylprednisolone | 1 | 2010 | 388 | 0.340 |
Why?
|
Delivery of Health Care | 3 | 2021 | 5304 | 0.310 |
Why?
|
Liver Abscess | 1 | 2007 | 82 | 0.300 |
Why?
|
Pregnancy Complications, Hematologic | 2 | 2020 | 183 | 0.290 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2010 | 640 | 0.290 |
Why?
|
Physicians | 2 | 2023 | 4554 | 0.290 |
Why?
|
Warfarin | 1 | 2015 | 1493 | 0.290 |
Why?
|
Klebsiella Infections | 1 | 2007 | 137 | 0.280 |
Why?
|
Pulmonary Fibrosis | 1 | 2010 | 526 | 0.280 |
Why?
|
Humans | 63 | 2023 | 742088 | 0.280 |
Why?
|
Cysts | 1 | 2011 | 676 | 0.270 |
Why?
|
Klebsiella pneumoniae | 1 | 2007 | 246 | 0.270 |
Why?
|
Endophthalmitis | 1 | 2007 | 263 | 0.250 |
Why?
|
Markov Chains | 2 | 2019 | 969 | 0.250 |
Why?
|
Cochlear Implants | 2 | 2021 | 339 | 0.250 |
Why?
|
Partial Thromboplastin Time | 2 | 2021 | 206 | 0.240 |
Why?
|
Primary Health Care | 2 | 2016 | 4551 | 0.220 |
Why?
|
Immunosuppressive Agents | 1 | 2016 | 4147 | 0.220 |
Why?
|
von Willebrand Disease, Type 2 | 1 | 2022 | 8 | 0.220 |
Why?
|
von Willebrand Disease, Type 1 | 1 | 2022 | 5 | 0.210 |
Why?
|
Factor XI Deficiency | 1 | 2021 | 18 | 0.210 |
Why?
|
Quality-Adjusted Life Years | 2 | 2019 | 1679 | 0.200 |
Why?
|
Glucocorticoids | 1 | 2010 | 2107 | 0.200 |
Why?
|
Blood Platelet Disorders | 1 | 2021 | 58 | 0.190 |
Why?
|
Multiple Myeloma | 1 | 2019 | 5169 | 0.190 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 20086 | 0.180 |
Why?
|
Cochlear Implantation | 2 | 2021 | 310 | 0.170 |
Why?
|
Thrombocythemia, Essential | 1 | 2020 | 103 | 0.170 |
Why?
|
Transsexualism | 1 | 2022 | 177 | 0.170 |
Why?
|
Thiophenes | 1 | 2023 | 590 | 0.170 |
Why?
|
Remote Consultation | 1 | 2021 | 238 | 0.170 |
Why?
|
Desensitization, Immunologic | 2 | 2021 | 483 | 0.170 |
Why?
|
Neuroma, Acoustic | 1 | 2023 | 450 | 0.170 |
Why?
|
Lymphopenia | 1 | 2021 | 285 | 0.160 |
Why?
|
Factor Xa | 1 | 2019 | 162 | 0.160 |
Why?
|
Dermatofibrosarcoma | 1 | 2018 | 62 | 0.160 |
Why?
|
Postpartum Hemorrhage | 1 | 2022 | 258 | 0.160 |
Why?
|
Abortion, Spontaneous | 2 | 2020 | 542 | 0.160 |
Why?
|
Helicobacter pylori | 1 | 2021 | 381 | 0.150 |
Why?
|
Helicobacter Infections | 1 | 2021 | 385 | 0.150 |
Why?
|
Heart Transplantation | 1 | 2010 | 3119 | 0.150 |
Why?
|
Live Birth | 1 | 2020 | 512 | 0.140 |
Why?
|
Sepsis | 1 | 2011 | 2589 | 0.140 |
Why?
|
Speech Perception | 1 | 2021 | 489 | 0.140 |
Why?
|
Morpholines | 1 | 2019 | 561 | 0.130 |
Why?
|
Medical Oncology | 2 | 2019 | 2235 | 0.130 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2023 | 1130 | 0.130 |
Why?
|
Hematologic Tests | 1 | 2016 | 238 | 0.130 |
Why?
|
Female | 22 | 2023 | 379592 | 0.130 |
Why?
|
Bone Marrow Diseases | 1 | 2017 | 230 | 0.130 |
Why?
|
Drug Monitoring | 1 | 2021 | 956 | 0.130 |
Why?
|
Anemia, Aplastic | 1 | 2017 | 226 | 0.130 |
Why?
|
Aminopyridines | 1 | 2019 | 541 | 0.130 |
Why?
|
Platelet Count | 3 | 2023 | 780 | 0.130 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2019 | 839 | 0.130 |
Why?
|
Anemia, Sickle Cell | 1 | 2023 | 1017 | 0.130 |
Why?
|
Rhode Island | 1 | 2015 | 347 | 0.120 |
Why?
|
Cochlea | 2 | 2021 | 828 | 0.120 |
Why?
|
Mentors | 1 | 2019 | 630 | 0.120 |
Why?
|
Burnout, Professional | 1 | 2023 | 690 | 0.120 |
Why?
|
Pyridones | 1 | 2019 | 712 | 0.120 |
Why?
|
Neoplasms | 3 | 2019 | 21596 | 0.120 |
Why?
|
Blood Platelets | 2 | 2023 | 2506 | 0.120 |
Why?
|
Pregnancy | 5 | 2022 | 29087 | 0.120 |
Why?
|
Internationality | 1 | 2019 | 1002 | 0.120 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2021 | 941 | 0.110 |
Why?
|
Career Choice | 1 | 2019 | 743 | 0.110 |
Why?
|
Aging | 2 | 2022 | 8626 | 0.110 |
Why?
|
Leukocytes | 1 | 2021 | 2039 | 0.110 |
Why?
|
Drug Hypersensitivity | 1 | 2021 | 883 | 0.110 |
Why?
|
Adult | 16 | 2023 | 213712 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 35342 | 0.100 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7276 | 0.100 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2019 | 987 | 0.100 |
Why?
|
Oxygen | 1 | 2023 | 4169 | 0.100 |
Why?
|
Fellowships and Scholarships | 1 | 2019 | 1066 | 0.100 |
Why?
|
Blood Coagulation Tests | 2 | 2022 | 263 | 0.100 |
Why?
|
Venous Thrombosis | 1 | 2020 | 1237 | 0.100 |
Why?
|
United States | 8 | 2023 | 69693 | 0.090 |
Why?
|
Oseltamivir | 1 | 2010 | 75 | 0.090 |
Why?
|
Specialization | 1 | 2015 | 777 | 0.090 |
Why?
|
Intensive Care Units | 2 | 2021 | 3679 | 0.090 |
Why?
|
Endothelium, Vascular | 1 | 2022 | 4455 | 0.090 |
Why?
|
Mastectomy | 1 | 2018 | 1789 | 0.090 |
Why?
|
Health Care Costs | 1 | 2023 | 3203 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2019 | 1575 | 0.090 |
Why?
|
Education, Medical | 1 | 2021 | 1717 | 0.090 |
Why?
|
Recombinant Proteins | 1 | 2019 | 6608 | 0.090 |
Why?
|
Azacitidine | 1 | 2010 | 347 | 0.080 |
Why?
|
Aortic Valve Stenosis | 1 | 2021 | 1941 | 0.080 |
Why?
|
Pyrazoles | 1 | 2019 | 1970 | 0.080 |
Why?
|
Neutrophils | 1 | 2021 | 3711 | 0.080 |
Why?
|
Internal Medicine | 1 | 2015 | 1009 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2018 | 2266 | 0.080 |
Why?
|
Physician's Role | 1 | 2015 | 942 | 0.080 |
Why?
|
Health Care Surveys | 1 | 2015 | 2451 | 0.080 |
Why?
|
Medicare | 2 | 2023 | 6532 | 0.080 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2275 | 0.080 |
Why?
|
Pulmonary Embolism | 1 | 2020 | 2370 | 0.080 |
Why?
|
Administration, Oral | 1 | 2015 | 3913 | 0.080 |
Why?
|
Antidotes | 2 | 2019 | 138 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2019 | 3584 | 0.070 |
Why?
|
Renal Dialysis | 1 | 2016 | 1780 | 0.070 |
Why?
|
Male | 13 | 2023 | 349538 | 0.070 |
Why?
|
Pregnancy Outcome | 1 | 2017 | 2795 | 0.070 |
Why?
|
Aged, 80 and over | 4 | 2021 | 57683 | 0.070 |
Why?
|
Pyrimidines | 1 | 2019 | 2933 | 0.070 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2010 | 457 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2011 | 12958 | 0.070 |
Why?
|
Drug Resistance, Viral | 1 | 2010 | 820 | 0.070 |
Why?
|
Immunocompromised Host | 1 | 2010 | 847 | 0.060 |
Why?
|
Bronchoscopy | 1 | 2010 | 860 | 0.060 |
Why?
|
Risk Factors | 4 | 2020 | 72145 | 0.060 |
Why?
|
Age Factors | 1 | 2021 | 18355 | 0.060 |
Why?
|
Spleen | 1 | 2011 | 2359 | 0.060 |
Why?
|
Cardiology | 1 | 2015 | 1658 | 0.060 |
Why?
|
Models, Biological | 1 | 2020 | 9581 | 0.060 |
Why?
|
Retrospective Studies | 5 | 2023 | 77098 | 0.060 |
Why?
|
Models, Statistical | 1 | 2018 | 5100 | 0.060 |
Why?
|
Anxiety | 1 | 2018 | 4279 | 0.060 |
Why?
|
Aged | 6 | 2023 | 162944 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2019 | 5522 | 0.050 |
Why?
|
Deamino Arginine Vasopressin | 1 | 2022 | 91 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3130 | 0.050 |
Why?
|
Oxyhemoglobins | 1 | 2023 | 216 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3236 | 0.050 |
Why?
|
Thrombopoietin | 1 | 2023 | 223 | 0.050 |
Why?
|
Epistaxis | 1 | 2022 | 111 | 0.050 |
Why?
|
Middle Aged | 9 | 2021 | 213127 | 0.050 |
Why?
|
Facial Nerve | 1 | 2023 | 271 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2010 | 6483 | 0.050 |
Why?
|
Prothrombin Time | 1 | 2020 | 119 | 0.050 |
Why?
|
Electronics | 1 | 2021 | 322 | 0.050 |
Why?
|
Blood Cell Count | 1 | 2021 | 402 | 0.040 |
Why?
|
Oximetry | 1 | 2023 | 467 | 0.040 |
Why?
|
Organoplatinum Compounds | 1 | 2021 | 408 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2016 | 8925 | 0.040 |
Why?
|
Factor VIII | 1 | 2022 | 348 | 0.040 |
Why?
|
Job Satisfaction | 1 | 2023 | 535 | 0.040 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2020 | 424 | 0.040 |
Why?
|
Influenza, Human | 1 | 2010 | 1472 | 0.040 |
Why?
|
Asia | 1 | 2021 | 607 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2018 | 5662 | 0.040 |
Why?
|
Hematologic Neoplasms | 1 | 2010 | 1820 | 0.040 |
Why?
|
Biopsy | 1 | 2010 | 6756 | 0.040 |
Why?
|
Medication Therapy Management | 1 | 2019 | 127 | 0.040 |
Why?
|
Depression | 1 | 2018 | 7733 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 425 | 0.040 |
Why?
|
Antiviral Agents | 1 | 2010 | 2978 | 0.040 |
Why?
|
Drug and Narcotic Control | 1 | 2019 | 146 | 0.040 |
Why?
|
Lactation Disorders | 1 | 2017 | 16 | 0.040 |
Why?
|
Enoxaparin | 1 | 2020 | 377 | 0.040 |
Why?
|
Nurse-Patient Relations | 1 | 2018 | 101 | 0.040 |
Why?
|
Health Services | 1 | 2023 | 758 | 0.040 |
Why?
|
Ferritins | 1 | 2020 | 590 | 0.040 |
Why?
|
Geography | 1 | 2019 | 669 | 0.040 |
Why?
|
Stress, Mechanical | 1 | 2022 | 1684 | 0.040 |
Why?
|
Gender Identity | 1 | 2022 | 681 | 0.040 |
Why?
|
Reference Standards | 1 | 2021 | 1020 | 0.040 |
Why?
|
Leukocyte Count | 1 | 2021 | 1583 | 0.040 |
Why?
|
Fibrinogen | 1 | 2020 | 894 | 0.040 |
Why?
|
Risk Assessment | 1 | 2018 | 23320 | 0.040 |
Why?
|
False Negative Reactions | 1 | 2017 | 587 | 0.030 |
Why?
|
Fetal Death | 1 | 2017 | 447 | 0.030 |
Why?
|
Health Plan Implementation | 1 | 2018 | 351 | 0.030 |
Why?
|
Mutation | 1 | 2020 | 29717 | 0.030 |
Why?
|
Estradiol | 1 | 2022 | 2021 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2023 | 3770 | 0.030 |
Why?
|
Melphalan | 1 | 2016 | 431 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 24913 | 0.030 |
Why?
|
Propensity Score | 1 | 2021 | 1771 | 0.030 |
Why?
|
Research | 1 | 2023 | 1999 | 0.030 |
Why?
|
Antithrombins | 1 | 2016 | 304 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2019 | 1126 | 0.030 |
Why?
|
Telomerase | 1 | 2017 | 729 | 0.030 |
Why?
|
Electrodes, Implanted | 1 | 2016 | 824 | 0.030 |
Why?
|
Neurosurgical Procedures | 1 | 2023 | 2002 | 0.020 |
Why?
|
Drug Costs | 1 | 2019 | 1104 | 0.020 |
Why?
|
Infertility, Female | 1 | 2017 | 784 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2018 | 20774 | 0.020 |
Why?
|
Leiomyoma | 1 | 2016 | 728 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2016 | 2236 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2023 | 62966 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 2021 | 2542 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3766 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2023 | 15244 | 0.020 |
Why?
|
Caregivers | 1 | 2019 | 2074 | 0.020 |
Why?
|
Critical Illness | 1 | 2021 | 2665 | 0.020 |
Why?
|
Motivation | 1 | 2018 | 1968 | 0.020 |
Why?
|
RNA | 1 | 2017 | 2747 | 0.020 |
Why?
|
Ultrasonography | 1 | 2020 | 5978 | 0.020 |
Why?
|
Chronic Disease | 1 | 2022 | 9144 | 0.020 |
Why?
|
Communication | 1 | 2021 | 3728 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13655 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14720 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10943 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5238 | 0.020 |
Why?
|
Logistic Models | 1 | 2019 | 13403 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8621 | 0.020 |
Why?
|
Disease Progression | 1 | 2021 | 13256 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7901 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2018 | 4229 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7153 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15530 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10232 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 20928 | 0.010 |
Why?
|
Animals | 2 | 2011 | 168561 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8077 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8328 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 40450 | 0.010 |
Why?
|
Atrial Fibrillation | 1 | 2016 | 5019 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29010 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2017 | 25575 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39004 | 0.010 |
Why?
|
Child | 1 | 2021 | 77478 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 85649 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 56350 | 0.010 |
Why?
|